The cellular and molecular contexts may also differ, such as is the case with AML, where resistance mechanisms include the emergence of monocytic subclones that rely on MCL-1, a shift driven by the differentiation state of cells [57]. The gene discussed is MCL1; the disease is acute myeloid leukemia.